These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18490505)

  • 1. Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcus aureus strains.
    Hoshi S; Kikuchi K; Sasaki T; Sotozono C; Kinoshita S; Hiramatsu K
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2970-3. PubMed ID: 18490505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
    Hesje CK; Borsos SD; Blondeau JM
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):329-34. PubMed ID: 19650708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
    Licata L; Smith CE; Goldschmidt RM; Barrett JF; Frosco M
    Antimicrob Agents Chemother; 1997 May; 41(5):950-5. PubMed ID: 9145850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strains.
    Farrell DJ; Liverman LC; Biedenbach DJ; Jones RN
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3631-4. PubMed ID: 21555765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.
    Fintelmann RE; Hoskins EN; Lietman TM; Keenan JD; Gaynor BD; Cevallos V; Acharya NR
    Arch Ophthalmol; 2011 Apr; 129(4):399-402. PubMed ID: 21482865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus.
    Blondeau JM; Borsos S; Hesje CK
    J Chemother; 2007 Apr; 19(2):146-51. PubMed ID: 17434822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
    Wu X; Jiang H; Xu Y; Yue W; Yang L; Song Z; Chen H; Liu T
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):420-7. PubMed ID: 22360669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriologic profile of the conjunctiva in the patients with dry eye.
    Hori Y; Maeda N; Sakamoto M; Koh S; Inoue T; Tano Y
    Am J Ophthalmol; 2008 Nov; 146(5):729-34. PubMed ID: 18672220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Ryan BM; Mazzucco CE; Lawrence LE; Ho H; Warr G; Barrett JF; Frosco M
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):27-34. PubMed ID: 11913498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Sasaki H; Fukuda M; Gordon YJ
    Jpn J Ophthalmol; 2008; 52(3):211-216. PubMed ID: 18661272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqueous penetration of gatifloxacin and levofloxacin into the rabbit aqueous humor following topical dosing.
    Levine JM; Noecker RJ; Lane LC; Snyder RW; Rapedius M; Blanchard J
    J Ocul Pharmacol Ther; 2004 Jun; 20(3):210-6. PubMed ID: 15279726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
    Kang SL; Rybak MJ; McGrath BJ; Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2702-9. PubMed ID: 7695250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/pharmacodynamic modelling of the bactericidal activity of free lung concentrations of levofloxacin and gatifloxacin against Streptococcus pneumoniae.
    Tasso L; de Andrade C; Dalla Costa T
    Int J Antimicrob Agents; 2011 Oct; 38(4):307-13. PubMed ID: 21802907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones.
    Hori Y; Nakazawa T; Maeda N; Sakamoto M; Yokokura S; Kubota A; Inoue T; Nishida K; Tano Y
    J Cataract Refract Surg; 2009 Mar; 35(3):475-9. PubMed ID: 19251140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis on susceptibility of ocular bacterial pathogens to four kinds of fluoroquinolone].
    Wang ZQ; Li L; Li R; Luo SY; Bai XQ; Liang QF; Deng SJ; Sun XG
    Zhonghua Yan Ke Za Zhi; 2008 Mar; 44(3):233-6. PubMed ID: 18785547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
    Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
    Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.
    Metzler K; Hansen GM; Hedlin P; Harding E; Drlica K; Blondeau JM
    Int J Antimicrob Agents; 2004 Aug; 24(2):161-7. PubMed ID: 15288315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones.
    Miyanaga M; Nejima R; Miyai T; Miyata K; Ohashi Y; Inoue Y; Toyokawa M; Asari S
    J Cataract Refract Surg; 2009 Nov; 35(11):1970-8. PubMed ID: 19878831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levofloxacin: serum bactericidal activity against methicillin-resistant Staphylococcus aureus isolates.
    Muller-Serieys C; Decré D; Benoit C; Bigot C; Maubert B; Carbon C
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():67-70. PubMed ID: 10404341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.